<DOC>
	<DOCNO>NCT00005108</DOCNO>
	<brief_summary>This study determine effect hormone replacement therapy ( estrogen alone estrogen progesterone ) wall artery postmenopausal woman . Inflammation stiffness artery wall two risk factor atherosclerosis-deposits fatty substance ( plaque ) block vessel , cause heart attack stroke . Estrogen raise level certain substance blood cause vessel inflammation lower level others . This study measure net effect estrogen artery wall inflammation stiffness . Postmenopausal woman good health may participate study . Volunteers screen eligibility complete medical history , heart examination , blood test . Participants randomly assign receive either : 1 ) hormone therapy ( estradiol 2 mg daily alone woman hysterectomy estradiol plus micronized progesterone 200 mg daily woman intact uterus ) ; 2 ) placebo ( look-alike pill contain active drug ) . Women group take pill 3 month , pill 1 month , crossover alternate therapy 3 month ( i.e. , original placebo group take hormone , hormone group take placebo ) . At end 3-month treatment period , participant undergo follow procedure assess blood vessel inflammation stiffness : 1 . Blood test - 60 cc ( 2 ounce ) blood draw measure level hormone , cholesterol , substance blood indicate inflammation vessel . 2 . Ultrasonography - ultrasound probe apply gently neck image right leave carotid artery ( artery neck lead brain ) . During procedure , heart 's electrical activity also monitor electrocardiogram blood pressure cuff wrap around arm obtain blood pressure measurement every 5 minute . 3 . Magnetic resonance imaging ( MRI ) - Images carotid artery take volunteer lie table narrow cylinder contain magnetic field . A padded sensor call MRI coil place neck earplug place ear muffle loud noise machine scan . During second half exam , gadolinium inject catheter ( thin , flexible tube ) insert vein . Gadolinium contrast agent use brighten scan image . Information study increase knowledge effect estrogen vessel wall inflammation . As , may use future help guide decision chronic hormone replacement therapy postmenopausal woman .</brief_summary>
	<brief_title>Effects Hormone Replacement Therapy Inflammation Stiffening Artery Walls</brief_title>
	<detailed_description>Vascular inflammation play important role pathogenesis atherosclerosis may contribute stiffen artery increase risk myocardial infarction stroke . Accordingly , therapy reduce vascular inflammation may reduce cardiovascular risk . The effect estrogen therapy serum marker inflammation postmenopausal woman divergent : Estrogen increase level C-reactive protein , interleukin-6 , matrix metalloproteinase-9 ( MMP-9 ) , decrease level soluble cell adhesion molecules ICAM-1 , VCAM-1 E-selectin . MMP-9 secrete macrophage cytokine-activated smooth muscle cell , increase expression vicinity atherosclerotic plaque . Although activation MMP-9 estrogen could deleterious woman coronary artery disease digest fibrous cap vulnerable plaque provoke thrombosis ( consistent Heart Estrogen/progestin Replacement Study ) , activation MMP-9 healthy postmenopausal woman may remove excess matrix protein contribute arterial stiffness ( reduce compliance ) , thus reduce cardiovascular risk ( consistent Nurses ' Health Study ) . Reduction level cell adhesion molecule might protect new plaque development group woman . The purpose protocol determine net effect estrogen therapy 1 ) vascular inflammation postmenopausal woman , use MRI/MRA image carotid artery , 2 ) arterial compliance , derive carotid ultrasonography blood pressure measurement .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Ability comprehend unwillingness sign consent form . No use estrogen therapy within 2 month study . No history breast cancer , uterine cancer , estrogendependent tumor . No history deep vein thrombosis pulmonary embolus . No cigarette smoker ( within 2 year ) . No diabetes mellitus ( FBS great 120 mg/dL ) . Triglycerides le 400 mg/dL . Blood pressure le 160/90 without antihypertensive therapy . No history coronary artery disease . No history carotid artery disease stroke . No history pancreatitis . No history claustrophobia . No history involuntary motion disorder . Specific MRI exclusion criterion ( i.e. , pacemaker , cochlear implant , AICD , internal infusion pump , metal implant clip field view ) . No systemic inflammatory disorder ( e.g. , rheumatoid arthritis , periarteritis nodosa , systemic lupus erythromatosus , temporal arteritis ) . Must need chronic aspirin NSAID therapy .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2002</verification_date>
	<keyword>Menopause</keyword>
	<keyword>Atherosclerosis</keyword>
	<keyword>Estrogen</keyword>
	<keyword>MRI</keyword>
	<keyword>Ultrasound</keyword>
</DOC>